Mutation in the tumour-suppressor gene p53 is the most frequent alteration found in human tumours (Ko and Prives. 1996) . Wildtype p53 is a transcription and translation regulator acting on a variety of genes involved in the control of cell cycle and differentiation (Ewen and Miller. 1996; Bourdon et al. 1997 ) that can be either activated or repressed. These genes include cytokines and growth factors (Fujiwara et al. 1994; Shin et al. 1995 : Pesch et al. 1996 . Therefore. impaired p53 function could determine a deregulated production of cytokines/growth factors. which could be of advantage for the malignant phenotype (Baserga. 1994) . Rhabdomyosarcoma. the most frequent softtissue sarcoma in childhood (Pappo et al. 1995) . frequently shows impaired p53 function (Felix et al. 1992 : Diller et al. 1995 : Keleti et al. 1996 and produces a variety of growth factors (Schweigerer et al. 1987; El-Badry et al. 1990 : De Giovanni et al. 1995 that could be subject to transcription control by p53 (Fujiwara et al. 1994 : Shin et al. 1995 : Zhang et al. 1996 . We recently found that rhabdomyosarcoma cell lines express and secrete interleukin 15 (IL-15) (Lollini et al. 1997 ). This cytokine. controlled at both transcription and translation levels. has an IL-2-like activity (Tagaya et al. 1996; Onu et al. 1997) and protects from apoptosis both in vitro and in vivo . IL-15 transcription has been found in a variety of normal and neoplastic tissues (Grabstein et al. 1994 : Tagaya et al. 1996 . but secretion of IL-15 protein is restricted to some normal cell types and a few neoplastic cell lines.
Received 5 December 1997 Revised 27 May 1998 Accepted 28 May 1998 Correspondence to: C De Giovanni, Istituo di Cancerologia, Vkale Filopanti 22, Bolgna, Italy including rhabdomyosarcoma (Lollini et al. 1997) . To test whether impaired p53 function could play a role in IL-15 production. we transfected p53 gene in rhabdomyosarcoma cells and studied the effects on proliferation and on IL-15 transcription and production. Because cells of the muscle lineage can respond to exogenous IL-15 (Quinn et al. 1995) . expression of IL-15 receptors was also studied.
MATERIALS AND METHODS Cells and p53 gene transduction
Transduction of p53 gene was perforned in the human rhabdomyosarcoma cell line RD. which is known to harbour a mutation in codon 248 of the p53 gene (Felix et al. 1992) . Unless otherwise specified, cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 370C in a humidified 7% carbon dioxide atmosphere. All media constituents were purchased from Life Technologies. Milan. Italy. Plasmid pN53cG . carrying the temperature-sensitive p53 (ial-135) gene (ts-pS3) under the control of HaMSV-LTR and the selectable marker neo under the control of the RSV-LTR (Soddu et al. 1994) . and plasmid pRSVneo, carrying the selectable marker alone. were used for transfections. Approximately 3 x 106 exponentially growing RD rhabdomyosarcoma cells were transfected by electroporation (0.25 V. 960 jiF) with a gene pulser (BioRad Laboratonres. Hercules. CA. USA). Transfectants were cloned by limiting dilution in medium containing 0.75 mg mll G418 (Gibco BRL): one clone designated RD-tsp53 and one control designated RD-Neo were then studied. All transduced cells were routinely cultured at 37°C and shifted to the permissive temperature of 32°C for experimental studies.
To verify the transactivating action of ts-p53 gene product at the two culture temperatures, RD-Neo and RD-tsp53 transfectants were retransfected with a chloramphenicol acetyltransferase (CAT) reporter construct. Approximately 1 x 105 cells were plated in 60-mm dishes and transfected by calcium phosphate precipitation with PG 3CAT vector, carrying the CAT reporter gene driven by a polyomavirus promoter and 13 copies of the p53 consensusbinding sequence, or MG,5CAT vector with 15 copies of p53 nonbinding sites (Kem et al, 1992) (kindly provided by B Vogelstein). Soon after transfection, the cells were trypsinized and seeded in two new dishes, one of which was incubated at the permissive temperature and the other at the non-permissive temperature. After 48 h, the cells were lysed by freeze and thaw. CAT activity was determined using the two-phase fluorescence diffusion assay as described previously (Huff et al, 1993) ; counts per minute (c.p.m.)
were normalized to protein quantity.
Overexpression of wild-type p53 was also obtained by infection of RD cells with replication-defective, recombinant adenovirus carrying the human wild-type p53 cDNA (AdJL16), kindly provided by Silvia Bacchetti (Bacchetti and Graham, 1993) . Adherent RD cells were infected with 20 p.f.u. of Ad-p53 or d1312 control adenovinus, as described previously (Bacchetti and Graham, 1993 The proportion of apoptotic cells was studied on cells cultured as above, harvested and stained with Hoechst 33342; about 500 cells were scored for apoptotic bodies at 40x magnification.
In some experiments, cell cultures were treated with exogenous recombinant human IL-15 (Immunex, Seattle, WA, USA) at concentrations ranging from 100 to 1000 ng ml-, with anti-IL-15 monoclonal antibody M 11 (Immunex), at a final concentration of 3 jig ml-', or with anti-IL-15 polyclonal antibody (PeproTech, London, UK), at a final concentration of 5 jig ml-'; cell yield was determined 4 days later.
IL-15 expression
Cells transduced and cultured as above were utilized for RNA extraction, cDNA synthesis and RT-PCR, as reported previously (De Giovanni et al, 1995; Lollini et al, 1997) . RNA was extracted from at least three independent experinments in which control and non-biding site. CAT acivity (see Materials and methods) in cels cuitured at 320C is shown p53 transfectants were run in parallel; a cDNA panel from each expernment was tested in RT-PCR at least twice. Specific primer pairs for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and transforming growth factor 0, ) were obtained from Clontech (Palo Alto, CA. USA); prinmers for IL-15 were synthesized as reported previously (Lollini et al, 1997) .
Enzyme-inked immunosorbent assay (EUSA)
Cells were seeded at a concentration of 4-8 x 104 cells cm-2 and cultured at 37°C or 32°C. After 4 days, cultures were switched to RPMI + 0.5% FBS and incubation continued for a further 4 days at 37°C or at 32°C respectively. Cell supematants were then collected and IL-15 and TGF-01 prduction measured by means of ELISA purchased from Genzyme (Milan, Italy) and used according to the manufacturer's protocol. Supernatants for IL-15 determination were concentrated about 100 times as reported previously (Lollini et al. 1997) . At the same time, cell cultures were harvested and cell yield was determined. Cytokine production was expressed in pg per 106 cells. (Figure 1) . In RD-tsp53 transfectants, the induction of wild-type p53 conformation by culture at 32°C caused an almost complete arrest of cell growth ( Figure 2) ; the same cells cultured at 37°C showed a growth rate close to that of RD-Neo transfectant control cells.
Proportions of G, cells and of apoptotic cells were studied as potential causes of growth arrest induced by wild-type p53. The proportion of G, cells in RD-tsp53 transfectants cultured at 32°C showed a twofold increase over that of RD-Neo controls (72% and 36%, respectively) and a twofold increase in the proportion of apoptotic cells was also observed (3.9 ± 0.2% and 2.2 ± 0.2% respectively). The expression of mRNA for IL-15 was studied by RT-PCR in comparison with the expression of an unrelated growth factor (TGF-j1) and of a housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ( Figure 3A ). For each primer pair, the comparison between cDNAs derived from RD-Neo-and RD-tsp53-transfected cells was made in the exponential amplification phase. GAPDH showed that comparable cDNAs were obtained: PCR products of similar intensity were always observed after 15-25 amplification cycles. A down-modulation of IL-15 tanscript was observed in RD-tsp53-transfected cells at 370C and at 320C ( Figure  3A) . The mean decrease in the intensity of ethidium bromidestained bands, evaluated by densitometric analysis of five independent experiments, was: 38.4% ± 8.6 at 370C and 71.0% ± 7.3 at 32°C. Therefore, p53 down-modulation of 1L-15 was significantly higher (P = 0.016) in the wild-type confonnation. Down-modulation of the IL-15 transcript was constantly observed at different time points (e.g. from 2 to 12 days) after cell seeding.
The Figure 3A) . Mean decrease ± s.e. from three expenrments was 55.0% ± 14.0. Down-modulation of IL-15 mRNA was not due to an unspecifically decreased transcription activity because the expression of TGF-01 ( Figure 3A ) was slightly increased.
Post-transcriptional regulation of IL-15 protein production has been reported (Tagaya et al. 1996; Onu et al, 1997) . Therefore, the expression of secreted IL-15 protein was studied by an ELISA in supematants from RD-Neo and RD-tsp53 transfected cells ( Figure   3B ). A strong decrease in IL-15 production was already observed in RD-tsp53-transfected cells cultured at 370C and reached 90% reduction in 32°C cultures. This decrease is unlikely to be due to a non-specific decrease in metabolic activity because the production of TGF-13, whose baseline level was approximately 200-fold higher than that of IL-15. was actually increased under the same experimental conditions ( Figure 3B ). IL-15 binds to a membrane trimeric receptor. composed of a specific a-chain (IL-15Ra) and of >-and y-chains shared with other interleukins. Moreover, an unknown receptor has also been reported on mast cells (Tagaya et al. 1996) (Figure 4 ). Down-modulation of both total IL-15 membrane binding and of IL-15Ra was observed in RD-tsp53-transfected cells when the wild-type p53 conformation was induced by culture at 32°C. No difference was observed for TGF_j-RHg (Figure 4 ).
The treatment of RD-Neo and RD-tsp53 cells with exogenous recombinant human IL-15 at concentrations up to 1000 ng ml-'. as well as with either monoclonal or polyclonal anti-IL-15 antibodies, did not determine any change in cell proliferation and in expression of membrane glycoproteins such as HLA-A. B. C and CD44 (data not shown).
DISCUSSION
Human rhabdomyosarcoma cell line RD was transduced with p53 gene using two different vector systems: a ts-p53 plasmid (Soddu et al. 1994) . giving rise to stable transfectants in which wild-type p53 conformation is dependent upon the culture temperature. and an adenoviral vector carrying the wild-type p53 gene (Bacchetti and Graham. 1993) . in which a high transient wild-type p53 gene expression could be studied within a few days after infection. With both vector systems a down-modulation of IL-15 transcription was observed. This was not due to an unspecific decrease in transcription activity because expression of an unrelated growth factor (TGF-,B1) was slightly increased.
In the ts-p53 system. down-modulations of IL-15 transcription and production were also observed at the non-pennissive culture temperature. but the effect was significantly higher when the wild-type conformation was induced The effect of ts-p53 at 37°C could be related to its leakiness leading to a low amount of p53 in the wildtype conformation even at this temperature. However. experiments performed at a higher temperature (390C) confirmed that the decrease in IL-15 production was already observed with ts-p53 in the mutated conformation (data not shown). This suggests that both mutated and wild-type p53 were active in down-modulating IL-15. A similar phenomenon has been reported for other cytokines in expenmental models based on p53 mutants. e.g. IL-2 and IL4 are downmodulated by wild-type p53 as well as by deletion mutant p53 (Pesch et al. 1996) . TGF-j31 production was reported to be increased by both wild-type and mutated p53 in a glioblastoma cell line (Fujiwara et al. 1994) : this finding was extended to rhabdomyosarcoma by the present study with temperature-sensitive p53 gene products.
Although the above-mentioned IL-15 down-modulation was induced by both wild-type and mutated p53. other effects reported here were specific for p53 in the wild-type conformation. such as the growth arrest and the down-modulation of IL-15 receptors. These different behaviours could suggest that different mechanisms of p53 action are involved.
The presence of two p53 consensus sequences (the decamer PuPuPuCAf[T/APyPyPy) in the promoter and/or intronic regions of transactivated genes is a mechanism for p53 action as transcription factor (Bourdon et al. 1997) . has not yet been studied. but a p53 consensus sequence is present in the first intron of the IL-15 gene (GAACTGGCCT. position 18-27 of the sequence X91233 of GenBank).
An altemative to p53 consensus sequence binding. a 'nonspecific' mechanism based on p53 protein interaction with general transcription factors (Ko and Prives. 1996) . has been hypothesized for p53-induced down-modulation of IL-2 and IL-4 (Pesch et al. 1996) . IL-15 could share this mechanism with other interleukins. It must be remembered that IL-2 and IL-15 share receptors and activities (Grabstein et al. 1994; Tagaya et al. 1996) . Different p53 properties are related to different protein domains (Ko and Prives. 1996) . The ts-p53 gene we transfected harbours the temperature-sensitive Val-135 mutation in the DNA-binding central core region: alterations in this domain are responsible for properties of p53 leading to increased tumorigenic potential of cells resulting from changes in the ability to bind DNA. Val-135-mutated p53. however, could maintain, at least in part the ability to interact with general transcription factors through the aminoterminal domain. and this could lead to the transcription modulation by mutated p53 found for some cytokines (IL-2/4 and IL-15) (Pesch et al. 1996. present 
study).
It is also possible that some of the reported effects may be related to the state of the cell cycle machinery. not directly via p53 protein-protein interactions. The study of p21 --FI. a key downstream effector of p53 inhibition of cell cycle, will help in clarifying which mechanism is involved in different effects. P211lF' transfection (Meng et al. 1998) as well as treatment with exogenous p2l --'F peptides (Ball et al. 1996) could mimic p53 gene effects related to the state of cell cycle machinery. If p21 w-F does not mimic p53 effects. then it is more likely that the mechanism is related directly to p53 non-specific suppression of transcnrption.
A few IL-15 transcription modulators [e.g. UV radiations and yinterferon (IFN-y)] which lead to an up-modulation in normal cells are known so far (Tagaya et al. 1996) . Wild-type p53 leads to a decreased transcription: this is the first example of a downmodulation of IL-15.
The study of proliferative ability of stable RD-tsp53 transfectants showed that whereas at non-permissive temperature RD-tspS3-transduced cells had a growth curve close to RD-Neo control.
expression of p53 in the wild-type conformation led to an almost complete arrest of growth that could be determined by increase in GI arrest and in apoptosis rate. IL-15 protects from apoptosis both in vitro and in vivo (Angiolillo et al. 1997) . a phenomenon that is becoming more and more relevant for malignancy. IL-15 release in culture medium by rhabdomyosarcoma cells reached very low levels. of the order of 5-10 pg ml-' (present data and Lollini et al. 1997) . These levels are apparently lower than the threshold (about 25 pg mn-' ) required for in vitro lymphocyte proliferative responses (Grabstein et al. 1994: our unpublished data) . but in the local in vivo microenvironment short-range acting cytokines could have significant effects even at low concentrations. In particular. for IL-15 it has been suggested that receptorpositive cells able to release the cytokine could store a high concentration of IL-15 molecules on their surface. ready to be presented to passenger cells (Meazza et al. 1997) .
The possibility that IL-15 also acts in an autocrine way must be considered because RD rhabdomyosarcoma cells display both the specific a-chain of the trimeric receptor and IL-15 membrane binding, sites. as shown by the IL-15-IgG2b fusion protein. Some data on the effectiveness of IL-15 in muscle cells have been reported (Quinn et al. 1995) . We are currently studying whether autocnne effects (such as induction of proliferation or modifications in the expression of membrane molecules) are determined by IL-15 in rhabdomyosarcoma cells. However. in vitro treatment of rhabdomyosarcoma cells with exogenous recombinant IL-5 or with monoclonal and polyclonal anti-IL-15 neutralizing antibodies did not determine any modification in cell proliferation and in expression of membrane glycoproteins such as HLA-A. B. C and CD44. This is in accordance with the absence of proliferating effects observed in normal muscle cells (Quinn et al. 1995 ).
In conclusion. a selective down-modulation of both IL-15 and IL-15 receptors was found in rhabdomyosarcoma cells transduced with wild-type p53. This indicates a control of IL-15 circuits by p53 and suggests that further efforts should be directed to the study of the role of IL-15S in the progression of human rhabdomyosarcoma.
NOTE ADDED IN PROOF
The recent availability of the IL-15 promoter sequence (reported by Azimi et al. 1998 . Proc Natl Acad Sci USA 95: 2452) prompted us to reanalyse all available IL-15 sequences for p53 consensus binding sites. No consensus sequence was found in the IL-15 promoter. whereas several clusters of one. two and four decamers (with 0. 2 and 4 mismatch tolerance respectively) were found in introns 3. 4 and 5 and in the last exon (GenBank X91233).
